Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Ointments: SOP for Documentation of QC Test Results – V 2.0

Posted on By

SOP for Documentation of QC Test Results – V 2.0

Procedure for Documentation of QC Test Results

Department Quality Control (QC)/Quality Assurance (QA)
SOP No. SOP/Ointment/070
Supersedes V 1.0
Page No. Page X of Y
Issue Date [Insert Issue Date]
Effective Date [Insert Effective Date]
Review Date [Insert Review Date]

1. Purpose

The purpose of this Standard Operating Procedure (SOP) is to define a systematic approach for documenting Quality Control (QC) test results to ensure data integrity, regulatory compliance, and traceability in pharmaceutical manufacturing.

2. Scope

This SOP applies to all personnel in the Quality Control (QC) and Quality Assurance (QA) departments responsible for recording, reviewing, and maintaining QC test data for raw materials, in-process materials, and finished pharmaceutical products.

3. Responsibilities

  • Quality Control Analyst: Conducts QC tests and documents results in relevant records.
  • Quality Assurance Personnel: Reviews and approves test documentation for accuracy and compliance.
  • QC Supervisor: Ensures that all test results are recorded and reviewed as per company and regulatory requirements.
  • Data Integrity Officer (if applicable): Ensures compliance with ALCOA+ (Attributable, Legible, Contemporaneous, Original, Accurate, and Complete) principles.
See also  Ointments: SOP for Handling Materials with Specific Storage Conditions During Dispensing - V 2.0

4. Accountability

The QC and QA Managers are accountable for ensuring that all QC test results are documented accurately and securely maintained as per regulatory requirements.

5. Procedure

5.1 General Documentation Requirements

  • All QC test results must be recorded in a designated QC test logbook, worksheet, or electronic system.
  • Data entries must be in real-time, without backdating or postdating.
  • Corrections should be made with a single line strike-through, initialed, and dated.
  • All results must be reviewed and signed by a second QC personnel or supervisor.
  • Ensure proper documentation format, including:
    • Test Date and Time
    • Analyst Name and Signature
    • Test Method Reference
    • Equipment ID and Calibration Status
    • Test Results (Numerical and Observational)
    • Final Status (Pass/Fail)

5.2 Documentation of Specific QC Tests

5.2.1 Raw Material QC Tests

  • Record results for each raw material batch, including assay, moisture content, and microbial limits.
  • Compare results against approved raw material specifications.
See also  Ointments: SOP for Microbial Testing in Ointment Development - V 2.0

5.2.2 In-Process QC Tests

  • Document test results at defined stages of manufacturing.
  • Record parameters such as pH, viscosity, particle size, and microbial counts.

5.2.3 Finished Product QC Tests

  • Record physical, chemical, and microbiological test results.
  • Ensure all acceptance criteria are met before product release.

5.3 Electronic Documentation (If Applicable)

  • QC results recorded in an electronic system must have user authentication.
  • Audit trails must be enabled to track data modifications.
  • Electronic signatures must comply with 21 CFR Part 11 requirements.

5.4 Archiving and Retention of Records

  • Hard copy records must be stored in secured filing cabinets.
  • Electronic records should be backed up as per company data policies.
  • Retention periods must comply with GMP regulations (typically 5 – 10 years).

6. Abbreviations

  • GMP – Good Manufacturing Practices
  • QA – Quality Assurance
  • QC – Quality Control
  • ALCOA+ – Attributable, Legible, Contemporaneous, Original, Accurate, and Complete

7. Documents

  • QC Test Log (Annexure-1)
  • Final Product QC Report (Annexure-2)
See also  Ointments: SOP for Operational Qualification (OQ) of Mixing Tanks - V 2.0

8. References

  • WHO GMP Guidelines for Pharmaceutical Manufacturing
  • 21 CFR Part 11 – Electronic Records and Signatures
  • ICH Q7 – GMP for Active Pharmaceutical Ingredients

9. SOP Version

Version 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: QC Test Log

Date Batch Number Test Parameter Test Result Equipment ID Final Status Verified By
01/02/2025 OINT-101 pH 6.2 PH-200 Pass QA Officer
02/02/2025 OINT-102 Viscosity 45,000 cP VIS-300 Pass QA Officer

Annexure-2: Final Product QC Report

Date Batch Number Test Method Acceptance Criteria Result Final Status Approved By
01/02/2025 OINT-101 HPLC Assay 95% – 105% 98.5% Approved QA Head
02/02/2025 OINT-102 Microbial Testing Within limits Pass Approved QA Head

12. Revision History:

Revision Date Revision No. Details of Revision Reason for Revision Approved By
01/01/2024 1.0 Initial Version New SOP QA Head
01/02/2025 2.0 Updated SOP Format Standardization of Document QA Head
Ointments V 2.0 Tags:Ointment application SOP, Ointment batch record SOP, Ointment compounding SOP, Ointment dispensing SOP, Ointment filling SOP, Ointment formulation SOP, Ointment manufacturing SOP, Ointment microbiological testing SOP, Ointment pH testing SOP, Ointment production SOP, Ointment quality control SOP, Ointment stability study SOP, Pharmaceutical ointment SOP, SOP for ointment homogenization, SOP for ointment labeling, SOP for ointment mixing, SOP for ointment packaging, SOP for ointment preparation, SOP for ointment raw material testing, SOP for ointment shelf-life determination, SOP for ointment stability testing, SOP for ointment sterilization, SOP for ointment storage, SOP for ointment testing, SOP for ointment viscosity testing

Post navigation

Previous Post: Aerosol: SOP for Cross-Contamination Prevention in Dispensing Areas – V 2.0
Next Post: SOP for Packaging and Labeling Medical Devices

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version